nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.164	0.214	CbGbCtD
Isoniazid—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0929	0.121	CbGbCtD
Isoniazid—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0807	0.105	CbGbCtD
Isoniazid—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0672	0.0878	CbGbCtD
Isoniazid—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0563	0.0736	CbGbCtD
Isoniazid—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0537	0.0702	CbGbCtD
Isoniazid—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0455	0.0594	CbGbCtD
Isoniazid—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0352	0.046	CbGbCtD
Isoniazid—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.034	0.0444	CbGbCtD
Isoniazid—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0327	0.0428	CbGbCtD
Isoniazid—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0263	0.0344	CbGbCtD
Isoniazid—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0241	0.0315	CbGbCtD
Isoniazid—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.015	0.0196	CbGbCtD
Isoniazid—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0148	0.0193	CbGbCtD
Isoniazid—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0138	0.018	CbGbCtD
Isoniazid—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0094	0.0123	CbGbCtD
Isoniazid—Memory impairment—Alitretinoin—peripheral nervous system neoplasm	0.002	0.00853	CcSEcCtD
Isoniazid—Optic neuritis—Etoposide—peripheral nervous system neoplasm	0.00199	0.0085	CcSEcCtD
Isoniazid—Neurotoxicity—Epirubicin—peripheral nervous system neoplasm	0.00177	0.00756	CcSEcCtD
Isoniazid—Lymphadenopathy—Tretinoin—peripheral nervous system neoplasm	0.00176	0.00752	CcSEcCtD
Isoniazid—Lymphadenopathy—Isotretinoin—peripheral nervous system neoplasm	0.00176	0.00752	CcSEcCtD
Isoniazid—Diabetes mellitus—Tretinoin—peripheral nervous system neoplasm	0.00173	0.00737	CcSEcCtD
Isoniazid—Diabetes mellitus—Isotretinoin—peripheral nervous system neoplasm	0.00173	0.00737	CcSEcCtD
Isoniazid—Neurotoxicity—Doxorubicin—peripheral nervous system neoplasm	0.00164	0.00699	CcSEcCtD
Isoniazid—Vasculitis—Alitretinoin—peripheral nervous system neoplasm	0.00161	0.00686	CcSEcCtD
Isoniazid—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00159	0.00678	CcSEcCtD
Isoniazid—Liver injury—Cisplatin—peripheral nervous system neoplasm	0.00159	0.00678	CcSEcCtD
Isoniazid—Hepatocellular injury—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.0067	CcSEcCtD
Isoniazid—Psychotic disorder—Tretinoin—peripheral nervous system neoplasm	0.00147	0.00626	CcSEcCtD
Isoniazid—Psychotic disorder—Isotretinoin—peripheral nervous system neoplasm	0.00147	0.00626	CcSEcCtD
Isoniazid—Hepatocellular injury—Cisplatin—peripheral nervous system neoplasm	0.00134	0.00571	CcSEcCtD
Isoniazid—Lymphadenopathy—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.0057	CcSEcCtD
Isoniazid—Diabetes mellitus—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00559	CcSEcCtD
Isoniazid—Neuropathy peripheral—Topotecan—peripheral nervous system neoplasm	0.00115	0.00488	CcSEcCtD
Isoniazid—Neuropathy peripheral—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00485	CcSEcCtD
Isoniazid—Neuropathy peripheral—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00485	CcSEcCtD
Isoniazid—Neuropathy peripheral—Melphalan—peripheral nervous system neoplasm	0.00112	0.00478	CcSEcCtD
Isoniazid—Eruption—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00476	CcSEcCtD
Isoniazid—Optic neuritis—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00476	CcSEcCtD
Isoniazid—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00112	0.00476	CcSEcCtD
Isoniazid—Psychotic disorder—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00475	CcSEcCtD
Isoniazid—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00461	CcSEcCtD
Isoniazid—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00461	CcSEcCtD
Isoniazid—Hepatitis—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00444	CcSEcCtD
Isoniazid—Hepatitis—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00444	CcSEcCtD
Isoniazid—Optic neuritis—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00441	CcSEcCtD
Isoniazid—Eruption—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00441	CcSEcCtD
Isoniazid—Hepatitis—Melphalan—peripheral nervous system neoplasm	0.00103	0.00438	CcSEcCtD
Isoniazid—Neuritis—Epirubicin—peripheral nervous system neoplasm	0.000921	0.00392	CcSEcCtD
Isoniazid—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.000885	0.00377	CcSEcCtD
Isoniazid—Neuropathy peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000862	0.00367	CcSEcCtD
Isoniazid—Neuritis—Doxorubicin—peripheral nervous system neoplasm	0.000852	0.00363	CcSEcCtD
Isoniazid—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.000851	0.00363	CcSEcCtD
Isoniazid—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.000848	0.00361	CcSEcCtD
Isoniazid—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.000841	0.00358	CcSEcCtD
Isoniazid—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.000841	0.00358	CcSEcCtD
Isoniazid—Neuropathy peripheral—Vincristine—peripheral nervous system neoplasm	0.00083	0.00354	CcSEcCtD
Isoniazid—Malaise—Topotecan—peripheral nervous system neoplasm	0.000824	0.00351	CcSEcCtD
Isoniazid—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00082	0.0035	CcSEcCtD
Isoniazid—Malaise—Tretinoin—peripheral nervous system neoplasm	0.000817	0.00348	CcSEcCtD
Isoniazid—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.000817	0.00348	CcSEcCtD
Isoniazid—Liver injury—Epirubicin—peripheral nervous system neoplasm	0.000817	0.00348	CcSEcCtD
Isoniazid—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.000789	0.00336	CcSEcCtD
Isoniazid—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000785	0.00335	CcSEcCtD
Isoniazid—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000785	0.00335	CcSEcCtD
Isoniazid—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000775	0.0033	CcSEcCtD
Isoniazid—Discomfort—Topotecan—peripheral nervous system neoplasm	0.000769	0.00328	CcSEcCtD
Isoniazid—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.000762	0.00325	CcSEcCtD
Isoniazid—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000762	0.00325	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Epirubicin—peripheral nervous system neoplasm	0.000756	0.00322	CcSEcCtD
Isoniazid—Liver injury—Doxorubicin—peripheral nervous system neoplasm	0.000756	0.00322	CcSEcCtD
Isoniazid—Neuropathy peripheral—Cisplatin—peripheral nervous system neoplasm	0.000734	0.00313	CcSEcCtD
Isoniazid—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00073	0.00311	CcSEcCtD
Isoniazid—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000724	0.00309	CcSEcCtD
Isoniazid—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000724	0.00309	CcSEcCtD
Isoniazid—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000715	0.00305	CcSEcCtD
Isoniazid—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000711	0.00303	CcSEcCtD
Isoniazid—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000705	0.00301	CcSEcCtD
Isoniazid—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000705	0.00301	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.00298	CcSEcCtD
Isoniazid—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000696	0.00297	CcSEcCtD
Isoniazid—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.000688	0.00293	CcSEcCtD
Isoniazid—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.000687	0.00293	CcSEcCtD
Isoniazid—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.000673	0.00287	CcSEcCtD
Isoniazid—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00067	0.00285	CcSEcCtD
Isoniazid—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000669	0.00285	CcSEcCtD
Isoniazid—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.000668	0.00285	CcSEcCtD
Isoniazid—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000664	0.00283	CcSEcCtD
Isoniazid—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000664	0.00283	CcSEcCtD
Isoniazid—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000656	0.0028	CcSEcCtD
Isoniazid—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000656	0.00279	CcSEcCtD
Isoniazid—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000651	0.00278	CcSEcCtD
Isoniazid—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000651	0.00278	CcSEcCtD
Isoniazid—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000648	0.00276	CcSEcCtD
Isoniazid—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.000646	0.00275	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000644	0.00274	CcSEcCtD
Isoniazid—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000643	0.00274	CcSEcCtD
Isoniazid—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000643	0.00274	CcSEcCtD
Isoniazid—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000643	0.00274	CcSEcCtD
Isoniazid—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000643	0.00274	CcSEcCtD
Isoniazid—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00064	0.00273	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000639	0.00272	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000639	0.00272	CcSEcCtD
Isoniazid—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000638	0.00272	CcSEcCtD
Isoniazid—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000638	0.00272	CcSEcCtD
Isoniazid—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000637	0.00272	CcSEcCtD
Isoniazid—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.000636	0.00271	CcSEcCtD
Isoniazid—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000635	0.00271	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00063	0.00269	CcSEcCtD
Isoniazid—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00063	0.00268	CcSEcCtD
Isoniazid—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000623	0.00266	CcSEcCtD
Isoniazid—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00062	0.00264	CcSEcCtD
Isoniazid—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000615	0.00262	CcSEcCtD
Isoniazid—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00061	0.0026	CcSEcCtD
Isoniazid—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00061	0.0026	CcSEcCtD
Isoniazid—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000597	0.00255	CcSEcCtD
Isoniazid—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000595	0.00254	CcSEcCtD
Isoniazid—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000592	0.00252	CcSEcCtD
Isoniazid—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00059	0.00251	CcSEcCtD
Isoniazid—Lymphadenopathy—Epirubicin—peripheral nervous system neoplasm	0.000585	0.00249	CcSEcCtD
Isoniazid—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000585	0.00249	CcSEcCtD
Isoniazid—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000585	0.00249	CcSEcCtD
Isoniazid—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.00246	CcSEcCtD
Isoniazid—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000576	0.00246	CcSEcCtD
Isoniazid—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000574	0.00245	CcSEcCtD
Isoniazid—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000574	0.00244	CcSEcCtD
Isoniazid—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000571	0.00243	CcSEcCtD
Isoniazid—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000549	0.00234	CcSEcCtD
Isoniazid—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000549	0.00234	CcSEcCtD
Isoniazid—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000545	0.00232	CcSEcCtD
Isoniazid—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000545	0.00232	CcSEcCtD
Isoniazid—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000543	0.00231	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.00231	CcSEcCtD
Isoniazid—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000538	0.00229	CcSEcCtD
Isoniazid—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000535	0.00228	CcSEcCtD
Isoniazid—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000534	0.00228	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000531	0.00226	CcSEcCtD
Isoniazid—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000531	0.00226	CcSEcCtD
Isoniazid—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000531	0.00226	CcSEcCtD
Isoniazid—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000529	0.00225	CcSEcCtD
Isoniazid—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000528	0.00225	CcSEcCtD
Isoniazid—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000528	0.00225	CcSEcCtD
Isoniazid—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000526	0.00224	CcSEcCtD
Isoniazid—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000524	0.00223	CcSEcCtD
Isoniazid—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000521	0.00222	CcSEcCtD
Isoniazid—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000515	0.00219	CcSEcCtD
Isoniazid—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000507	0.00216	CcSEcCtD
Isoniazid—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000503	0.00215	CcSEcCtD
Isoniazid—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000498	0.00212	CcSEcCtD
Isoniazid—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000498	0.00212	CcSEcCtD
Isoniazid—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000494	0.0021	CcSEcCtD
Isoniazid—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000492	0.0021	CcSEcCtD
Isoniazid—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000487	0.00208	CcSEcCtD
Isoniazid—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000485	0.00207	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000484	0.00206	CcSEcCtD
Isoniazid—Malaise—Etoposide—peripheral nervous system neoplasm	0.000484	0.00206	CcSEcCtD
Isoniazid—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000483	0.00206	CcSEcCtD
Isoniazid—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000478	0.00204	CcSEcCtD
Isoniazid—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000474	0.00202	CcSEcCtD
Isoniazid—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00047	0.002	CcSEcCtD
Isoniazid—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00047	0.002	CcSEcCtD
Isoniazid—Rash—Topotecan—peripheral nervous system neoplasm	0.00047	0.002	CcSEcCtD
Isoniazid—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00047	0.002	CcSEcCtD
Isoniazid—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000468	0.00199	CcSEcCtD
Isoniazid—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000466	0.00199	CcSEcCtD
Isoniazid—Rash—Tretinoin—peripheral nervous system neoplasm	0.000466	0.00199	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000466	0.00199	CcSEcCtD
Isoniazid—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000466	0.00198	CcSEcCtD
Isoniazid—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000465	0.00198	CcSEcCtD
Isoniazid—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000464	0.00198	CcSEcCtD
Isoniazid—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.00197	CcSEcCtD
Isoniazid—Rash—Melphalan—peripheral nervous system neoplasm	0.00046	0.00196	CcSEcCtD
Isoniazid—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000455	0.00194	CcSEcCtD
Isoniazid—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000451	0.00192	CcSEcCtD
Isoniazid—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000446	0.0019	CcSEcCtD
Isoniazid—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.00189	CcSEcCtD
Isoniazid—Nausea—Topotecan—peripheral nervous system neoplasm	0.000443	0.00189	CcSEcCtD
Isoniazid—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000439	0.00187	CcSEcCtD
Isoniazid—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000439	0.00187	CcSEcCtD
Isoniazid—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000434	0.00185	CcSEcCtD
Isoniazid—Nausea—Melphalan—peripheral nervous system neoplasm	0.000434	0.00185	CcSEcCtD
Isoniazid—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000429	0.00183	CcSEcCtD
Isoniazid—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000429	0.00183	CcSEcCtD
Isoniazid—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000427	0.00182	CcSEcCtD
Isoniazid—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000427	0.00182	CcSEcCtD
Isoniazid—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000417	0.00178	CcSEcCtD
Isoniazid—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000415	0.00177	CcSEcCtD
Isoniazid—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000413	0.00176	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000412	0.00176	CcSEcCtD
Isoniazid—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000402	0.00171	CcSEcCtD
Isoniazid—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000398	0.0017	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.00168	CcSEcCtD
Isoniazid—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000394	0.00168	CcSEcCtD
Isoniazid—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000393	0.00167	CcSEcCtD
Isoniazid—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000389	0.00166	CcSEcCtD
Isoniazid—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000388	0.00165	CcSEcCtD
Isoniazid—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000384	0.00164	CcSEcCtD
Isoniazid—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000381	0.00162	CcSEcCtD
Isoniazid—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00038	0.00162	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000378	0.00161	CcSEcCtD
Isoniazid—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000378	0.00161	CcSEcCtD
Isoniazid—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000377	0.00161	CcSEcCtD
Isoniazid—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000377	0.00161	CcSEcCtD
Isoniazid—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000375	0.0016	CcSEcCtD
Isoniazid—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000361	0.00154	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.00153	CcSEcCtD
Isoniazid—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000359	0.00153	CcSEcCtD
Isoniazid—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000359	0.00153	CcSEcCtD
Isoniazid—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000356	0.00152	CcSEcCtD
Isoniazid—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.00151	CcSEcCtD
Isoniazid—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000352	0.0015	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.00149	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.00148	CcSEcCtD
Isoniazid—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000346	0.00147	CcSEcCtD
Isoniazid—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00147	CcSEcCtD
Isoniazid—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000344	0.00146	CcSEcCtD
Isoniazid—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000343	0.00146	CcSEcCtD
Isoniazid—Rash—Vincristine—peripheral nervous system neoplasm	0.000341	0.00145	CcSEcCtD
Isoniazid—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000333	0.00142	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.00142	CcSEcCtD
Isoniazid—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000322	0.00137	CcSEcCtD
Isoniazid—Nausea—Vincristine—peripheral nervous system neoplasm	0.000321	0.00137	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.00136	CcSEcCtD
Isoniazid—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000314	0.00134	CcSEcCtD
Isoniazid—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000304	0.00129	CcSEcCtD
Isoniazid—Rash—Cisplatin—peripheral nervous system neoplasm	0.000301	0.00128	CcSEcCtD
Isoniazid—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000284	0.00121	CcSEcCtD
Isoniazid—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000279	0.00119	CcSEcCtD
Isoniazid—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000278	0.00119	CcSEcCtD
Isoniazid—Rash—Etoposide—peripheral nervous system neoplasm	0.000276	0.00118	CcSEcCtD
Isoniazid—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000271	0.00116	CcSEcCtD
Isoniazid—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00111	CcSEcCtD
Isoniazid—Nausea—Etoposide—peripheral nervous system neoplasm	0.00026	0.00111	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.0011	CcSEcCtD
Isoniazid—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00108	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00107	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00103	CcSEcCtD
Isoniazid—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00102	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000997	CcSEcCtD
Isoniazid—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000997	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000947	CcSEcCtD
Isoniazid—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000939	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000922	CcSEcCtD
Isoniazid—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00092	CcSEcCtD
Isoniazid—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000909	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000903	CcSEcCtD
Isoniazid—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000901	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000869	CcSEcCtD
Isoniazid—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000861	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000851	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000841	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000835	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000834	CcSEcCtD
Isoniazid—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000826	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000797	CcSEcCtD
Isoniazid—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000181	0.00077	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000765	CcSEcCtD
Isoniazid—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00075	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000713	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000694	CcSEcCtD
Isoniazid—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000665	CcSEcCtD
Isoniazid—Rash—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000659	CcSEcCtD
Isoniazid—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000621	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000615	CcSEcCtD
Isoniazid—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00061	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000575	CcSEcCtD
